¼¼°èÀÇ Èä°­ ¹è¾× ±â±â ½ÃÀå
Thoracic Drainage Devices
»óǰÄÚµå : 1765430
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 194 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Èä°­ ¹è¾× ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 11¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 8¾ï 5,870¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â Èä°­ ¹è¾× ±â±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ 2024-2030³â¿¡ CAGR 4.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 11¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÈäºÎ¿Ü°ú¡¤È£Èí±â°ú´Â CAGR 5.1%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 5¾ï 2,860¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÀå¿Ü°ú ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 3,520¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Èä°­ ¹è¾× ±â±â ½ÃÀåÀº 2024³â¿¡ 2¾ï 3,520¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 4.4%·Î 2030³â±îÁö 1¾ï 7,690¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 4.4%¿Í 3.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è Èä°­ ¹è¾× ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

Èä°­ ¹è¾× ±â±â¶õ ¹«¾ùÀ̸ç, ¿Ö ÀÇ·á ÇöÀå¿¡¼­ ÇʼöÀûÀΰ¡?

Èä°­ ¹è¾× ±â±â´Â ±âÈä, Èä¼ö, ³óÈä µî ȯÀÚÀÇ Èä°­ ¶Ç´Â Èä°­¿¡¼­ °ø±â, ¾×ü ¹× °í¸§À» Á¦°ÅÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±¸´Â Á¤»óÀûÀÎ Èä°­ ³» ¾Ð·ÂÀ» ÀçÈ®¸³Çϰí È¿°úÀûÀΠȣÈí ±â´É¿¡ ÇʼöÀûÀÎ ÆóÀÇ È®ÀåÀ» ÃËÁøÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °¡Àå ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â Èä°­ ¹è¾× ±â±â¿¡´Â Èä°­°ü(Èä°­·ç°ü), È丷 Ä«Å×ÅÍ, ÀϹæÇâ ¹ëºê µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ©ºê´Â ÀϹÝÀûÀ¸·Î ÀÇ·á Àü¹®°¡°¡ »ðÀÔÇÏ°í ¹è¾× ½Ã½ºÅÛ¿¡ ¿¬°áÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±¸¸¦ ÀûÀýÈ÷ »ç¿ëÇϸé ȯÀÚÀÇ ¿¹Èĸ¦ Å©°Ô °³¼±Çϰí ÇÕº´ÁõÀ» ÁÙÀ̸ç ÀÔ¿ø ±â°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü ¼¼°èÀûÀ¸·Î Èä°­ ¹è¾× ±â±âÀÇ º¸±ÞÀº È£Èí±âÁúȯ, ¿Ü»ó, ÈäºÎ ÁúȯÀÇ È¿°úÀûÀÎ °ü¸®°¡ ÇÊ¿äÇÑ ¿Ü°ú ¼ö¼úÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î °í·ÉÈ­¿Í ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD) ¹× Æó¾Ï°ú °°Àº ¸¸¼º È£Èí±âÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Èä°­ ¹è¾× ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ¼Òħ½ÀÀû ¼ö¼ú ±â¹ýÀÇ ¹ßÀü°ú ÈäºÎ ¼ö¼ú °Ç¼öÀÇ Áõ°¡·Î ÀÎÇØ ½Å·ÚÇÒ ¼ö ÀÖ°í È¿À²ÀûÀÎ Èä°­ ¹è¾× ±â±âÀÇ Çʿ伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ÁßȯÀÚ Ä¡·á ȯ°æ¿¡¼­ ȯÀÚÀÇ ¾ÈÀü°ú °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÁßÁ¡À» µÎ¸é¼­ ¼¼°è Èä°­ ¹è¾× ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº Èä°­ ¹è¾× ±â±âÀÇ °³¹ß ¹× Àû¿ëÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀ¸·Î Èä°­ ¹è¾× ±â±âÀÇ µðÀÚÀÎ, ±â´É ¹× ¾ÈÀü¼ºÀÌ Å©°Ô Çâ»óµÇ¾î ÀÇ·áÁø¿¡°Ô º¸´Ù È¿°úÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ Èä°­ ¹è¾× ±â±â¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ Çõ½Å Áß Çϳª´Â °ø±â ¿ª·ù¸¦ ¹æÁöÇÏ°í ¾ÈÀüÇÑ Ã¼¾× äÃë ȯ°æÀ» º¸ÀåÇÏ´Â ¿öÅͽǸµ ¸ÞÄ¿´ÏÁò°ú °°Àº ±â´ÉÀ» ÅëÇÕÇÑ Æó¼âÇü ¹è¾× ½Ã½ºÅÛÀÇ °³¹ßÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ½Ã½ºÅÛÀº °ø±â ´©Ãâ ¹× °¨¿°°ú °°Àº ÀáÀçÀû ÇÕº´Áõ¿¡ ´ëÇÑ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í, ÀÓ»óÀǰ¡ ½±°Ô °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ, ¾Ð·Â ¼¾¼­¿Í ¸ð´ÏÅ͸µ ±â¼úÀ» Èä°­ ¹è¾× ±â±â¿¡ ÅëÇÕÇÏ¿© ÁÖÀÔ·®°ú Èä°­ ³» ¾Ð·ÂÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇÒ ¼ö ÀÖ¾î ÀÇ·áÁøÀÌ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÓ»óÀû ÆÇ´ÜÀ» ½Å¼ÓÈ÷ ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

Èä°­ ¹è¾× ±â±â ½ÃÀåÀ» ÁÖµµÇÏ´Â ¶Ç ´Ù¸¥ ÁÖ¿ä ±â¼ú ¹ßÀüÀº ȯÀÚÀÇ Æí¾ÈÇÔÀ» ³ôÀ̰í ÇÕº´ÁõÀ» ÁÙÀÌ´Â Çõ½ÅÀûÀÎ ¼ÒÀç¿Í µðÀÚÀÎÀÇ °³¹ßÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, »ýüÀûÇÕ¼ºÀÌ ³ôÀº ¼ÒÀç¿Í ºÎµå·¯¿î Ä«Å×ÅÍ ¼³°èÀÇ ¹ßÀüÀ¸·Î Èä°­ ¹è¾×°üÀº ȯÀÚ¿¡°Ô ºÎ´ãÀÌ Àû°í Æí¾ÈÇÔÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ ±â¼ú ¹× ½º¸¶Æ® ±â¼úÀÇ µµÀÔÀ¸·Î Èä°­ ¹è¾× ½Ã½ºÅÛ°ú ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× ÅëÇÕÀÌ ¿ëÀÌÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀ» ÅëÇØ ÁÖÀÔ·®, ¾Ð·Â º¯È­, ȯÀÚ ¹ÝÀÀÀ» ¿øÈ°ÇÏ°Ô ±â·ÏÇÒ ¼ö ÀÖ¾î ÀÓ»ó °ü¸® °­È­ ¹× °á°ú °³¼±¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å°ú ÇÔ²² ȯÀÚÀÇ ¾ÈÀü°ú Æí¾ÈÇÔÀÌ °­Á¶µÇ¸é¼­ Èä°­ ¹è¾× ±â±â ½ÃÀåÀº Å©°Ô º¯È­Çϰí ÀÖ½À´Ï´Ù.

´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ Èä°­ ¹è¾× ±â±âÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

Èä°­ ¹è¾× ±â±âÀÇ Ã¤ÅÃÀº È£Èí±âÁúȯÀÇ ¹ß»ý·ü Áõ°¡, ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â È£Èí±âÁúȯ ¹× ÈäºÎ °³ÀÔÀÌ ÇÊ¿äÇÑ ÁúȯÀÇ ¹ß»ý·ü Áõ°¡ÀÔ´Ï´Ù. Æó·Å, Æó¾Ï, ½ÉºÎÀü µîÀÇ ÁúȯÀº Á¾Á¾ Èä°­ ³»¿¡ ¾×ü¿Í °ø±â°¡ ÃàÀûµÇ±â ¶§¹®¿¡ È¿°úÀûÀÎ °ü¸®¸¦ À§ÇØ Èä°­ ¹è¾× ±â±â¸¦ »ç¿ëÇØ¾ß ÇÕ´Ï´Ù. Àα¸ °í·ÉÈ­¿Í ¸¸¼º È£Èí±âÁúȯÀÇ Áõ°¡·Î ÀÎÇØ º´¿ø ¹× ÀÇ·á ½Ã¼³¿¡¼­ ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ÀÌ·¯ÇÑ Áõ»óÀ» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ Èä°­ ¹è¾× ±â±âÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Èä°­ ¹è¾× ±â±âÀÇ Ã¤Åÿ¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í È¿°úÀûÀÎ ÀÓ»ó °á°ú¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÇ·áÀÇ Áú°ú ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ±â°üÀº ÇÕº´Áõ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â Èä°­ ¹è¾× ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ¿ª·ù ¹æÁö ¹ëºê ¹× °¨¿° Á¦¾î ¸ÞÄ¿´ÏÁò°ú °°Àº ÃֽŠÈä°­ ¹è¾× ±â±â¿¡ žÀçµÈ °í±Þ ±â´ÉÀº ÀÌ·¯ÇÑ Á¦Ç°ÀÇ Àü¹ÝÀûÀÎ ¾ÈÀü¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ, Èä°­ ¹è¾× ±â±âÀÇ ¿Ã¹Ù¸¥ »ç¿ë¹ý¿¡ ´ëÇÑ ÀÇ·á Àü¹®°¡¸¦ À§ÇÑ ±³À° ÇÁ·Î±×·¥µµ ȯÀÚ °ü¸®¿Í °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ÈÀü¼º°ú È¿°ú¿¡ ´ëÇÑ °ü½ÉÀº ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ Èä°­ ¹è¾× ±â±âÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¼ö¼ú ¹× ÀÀ±Þ ÀÇ·á ºÐ¾ß¿¡¼­ ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ Èä°­ ¹è¾× ±â±âÀÇ Ã¤Åÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÇ·áÁøÀº ȯÀÚÀÇ ¿Ü»óÀ» ÁÙÀ̰í, ȸº¹ ½Ã°£À» ´ÜÃàÇϸç, ¼ö¼ú °á°ú¸¦ °³¼±ÇÏ´Â ±â¼úÀ» Á¡Á¡ ´õ ¼±È£Çϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¸ñÇ¥¸¦ ÃËÁøÇÏ´Â Èä°­ ¹è¾× ±â±â°¡ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡¸¦ »ç¿ëÇϸé ÈäºÎ ÇÕº´ÁõÀ» ÁÖº¯ Á¶Á÷ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϸ鼭 È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼úÀÇ Ãß¼¼´Â ƯÈ÷ ºñµð¿À º¸Á¶ Èä°­°æ ¼ö¼ú(VATS)°ú °°ÀÌ ¼ö¼ú ÈÄ È¸º¹¿¡ È¿°úÀûÀÎ ¹è¾× ¼Ö·ç¼ÇÀÌ Áß¿äÇÑ ¼ö¼ú¿¡¼­ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃÖ¼Òħ½ÀÀû Ä¡·á·ÎÀÇ ÀüȯÀº Èä°­ ¹è¾× ±â±â ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Èä°­ ¹è¾× ±â±â ¼¼°è ½ÃÀå ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

Èä°­ ¹è¾× ±â±â ¼¼°è ½ÃÀå ¼ºÀåÀº ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ȯÀÚ Áß½É Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í ¾çÁúÀÇ ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇϱâ À§ÇÑ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡ÀÔ´Ï´Ù. ƯÈ÷ ½ÅÈï±¹¿¡¼­´Â Á¤ºÎ ¹× ÀÇ·á±â°üÀÌ ÀÇ·á ½Ã¼³ °³¼±¿¡ ÀÚ¿øÀ» ÅõÀÔÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Èä°­ ¹è¾× ½Ã½ºÅÛÀ» Æ÷ÇÔÇÑ Ã·´Ü ÀÇ·á±â±âÀÇ Ã¤Åà Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. È£Èí±âÁúȯÀÇ È¿°úÀûÀÎ °ü¸®¿Í ÈäºÎ °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí Èä°­ ¹è¾× ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿øµ¿·ÂÀº ȯÀÚ Ä¡·á¿Í ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº µðÁöÅÐ ¸ð´ÏÅ͸µ, »ýüÀûÇÕ¼º Çâ»ó, »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀÎ µî ÷´Ü ±â´ÉÀ» ÅëÇÕÇÑ ÃֽŠÈä°­ ¹è¾× ±â±â¸¦ »ç¿ëÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù´Â °ÍÀ» ÀνÄÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ÈäºÎ ½Ã¼úÀÇ È¿À²¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ °æÇè°ú °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ´õ ³ªÀº ÀÓ»ó °ü¸®¸¦ º¸ÀåÇϱâ À§ÇØ Ã·´Ü ÀÇ·á ±â¼úÀÇ µµÀÔ¿¡ ´ëÇÑ Á߿伺ÀÌ °­Á¶µÇ¸é¼­ ÀÇ·á ȯ°æ Àü¹Ý¿¡ °ÉÃÄ Èä°­ ¹è¾× ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ȯÀÚ Áß½É Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ Èä°­ ¹è¾× ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾ º¸´Ù °³ÀÎÈ­µÇ°í È¿°úÀûÀÎ Ä¡·á¹ýÀ¸·Î ÀüȯµÊ¿¡ µû¶ó ȯÀÚÀÇ Æí¾ÈÇÔ, ¾ÈÀü¼º, ÆíÀǼºÀ» ¿ì¼±½ÃÇÏ´Â Èä°­ ¹è¾× ±â±âÀÇ Ã¤ÅÃÀÌ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. °³¹ß¾÷üµéÀº ÀÌ·¯ÇÑ Ãß¼¼¿¡ ¹ß¸ÂÃç º¸´Ù »ç¿ëÇϱ⠽±°í, ºÒÆíÇÔÀÌ ÀûÀ¸¸ç, ºü¸¥ ȸº¹À» ÃËÁøÇÏ´Â Àåºñ¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ Áß½ÉÀÇ Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» ã°í ÀÖÀ¸¸ç, ÀÌ´Â Èä°­ ¹è¾× ±â±â ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÀÇ·á Àü¹®°¡¸¦ À§ÇÑ ±³À° ¹× ±³À° ÇÁ·Î±×·¥ÀÇ ¹ßÀüÀº Èä°­ ¹è¾× ±â±â ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÇ·á ±â°üÀÌ Á÷¿øÀÇ ±â¼ú°ú Áö½ÄÀ» Çâ»ó½Ã۱â À§ÇØ ±³À° ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÅõÀÚÇÔ¿¡ µû¶ó Èä°­ ¹è¾× ±â±âÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±³À°ÀÌ °³¼±µÇ¸é ȯÀÚ °ü¸® °³¼±, ÇÕº´Áõ °¨¼Ò, ÀÓ»ó °á°ú °³¼±À¸·Î À̾îÁö±â ¶§¹®¿¡ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â ÀÌ·¯ÇÑ ÀåÄ¡¸¦ ´õ ±¤¹üÀ§ÇÏ°Ô Ã¤ÅÃÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ Èä°­ ¹è¾× ±â±âÀÇ »óȲÀ» °è¼Ó Çü¼ºÇϰí Àֱ⠶§¹®¿¡ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ȯÀÚ Áß½É Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µîÀ» ¹è°æÀ¸·Î ½ÃÀåÀº °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀÔ´Ï´Ù.

ºÎ¹®

¿ëµµ(ÈäºÎ¿Ü°ú¡¤È£Èí±â°ú, ½ÉÀå¿Ü°ú, ÀÏ¹Ý ÁýÁß Ä¡·á¡¤ÀÀ±ÞÀÇ·á, °¨¿°Áõ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Thoracic Drainage Devices Market to Reach US$1.1 Billion by 2030

The global market for Thoracic Drainage Devices estimated at US$858.7 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Thoracic Surgery & Pulmonology, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$528.6 Million by the end of the analysis period. Growth in the Cardiac Surgery segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$235.2 Million While China is Forecast to Grow at 4.4% CAGR

The Thoracic Drainage Devices market in the U.S. is estimated at US$235.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$176.9 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Thoracic Drainage Devices Market - Key Trends & Drivers Summarized

What Are Thoracic Drainage Devices and Why Are They Essential in Medical Practice?

Thoracic drainage devices are medical instruments used to remove air, fluid, or pus from the pleural cavity or thoracic space in patients suffering from conditions such as pneumothorax, pleural effusion, or empyema. These devices are crucial for re-establishing normal intrathoracic pressure and facilitating lung expansion, which is vital for effective respiratory function. The most commonly used thoracic drainage devices include chest tubes (thoracostomy tubes), pleural catheters, and one-way valves. They are typically inserted by healthcare professionals and connected to a drainage system that allows for continuous monitoring and evacuation of trapped fluids or air. The proper use of these devices can significantly improve patient outcomes, reduce complications, and shorten hospital stays.

The global adoption of thoracic drainage devices is driven by the increasing prevalence of respiratory diseases, trauma cases, and surgical procedures that require effective management of thoracic conditions. As the global population ages and the incidence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer rises, the demand for thoracic drainage solutions is growing. Additionally, advancements in minimally invasive surgical techniques and an increasing number of thoracic surgeries are further fueling the need for reliable and efficient thoracic drainage devices. The focus on improving patient safety and outcomes in critical care settings is propelling the expansion of the global thoracic drainage devices market.

How Are Technological Advancements Shaping the Development and Application of Thoracic Drainage Devices?

Technological advancements are significantly enhancing the design, functionality, and safety of thoracic drainage devices, making them more effective and user-friendly for healthcare providers. One notable innovation is the development of closed drainage systems that incorporate features such as water seal mechanisms, which prevent the backflow of air and ensure a safe environment for fluid collection. These advanced systems offer improved security against potential complications, such as air leaks and infection, while facilitating easier management for clinicians. Additionally, the integration of pressure sensors and monitoring technologies into thoracic drainage devices is enabling real-time tracking of fluid output and intrathoracic pressure, allowing healthcare providers to make informed clinical decisions promptly.

Another key technological advancement driving the thoracic drainage devices market is the development of innovative materials and designs that enhance patient comfort and reduce complications. For example, advances in biocompatible materials and softer catheter designs are making thoracic drainage tubes less intrusive and more comfortable for patients. Furthermore, the introduction of digital and smart technologies is facilitating better communication and integration of thoracic drainage systems with electronic health records (EHRs). These technologies enable seamless documentation of fluid outputs, pressure changes, and patient responses, supporting enhanced clinical management and improved outcomes. The emphasis on patient safety and comfort, along with technological innovations, is transforming the thoracic drainage devices market.

What Factors Are Driving the Adoption of Thoracic Drainage Devices Across Various Healthcare Settings?

The adoption of thoracic drainage devices is being driven by several key factors, including the increasing incidence of respiratory disorders, rising awareness of patient safety, and the growing focus on minimally invasive procedures. One of the primary drivers is the increasing incidence of respiratory disorders and conditions requiring thoracic intervention. Diseases such as pneumonia, lung cancer, and heart failure often lead to the accumulation of fluid or air in the pleural cavity, necessitating the use of thoracic drainage devices for effective management. The aging population, combined with the rise in chronic respiratory diseases, is contributing to a growing demand for these devices in hospitals and healthcare facilities. As healthcare providers seek to manage these conditions effectively, the adoption of thoracic drainage devices is expected to rise.

Another significant factor influencing the adoption of thoracic drainage devices is the rising awareness of patient safety and the need for effective clinical outcomes. With a greater emphasis on quality care and patient safety, healthcare institutions are increasingly investing in reliable thoracic drainage solutions that minimize the risk of complications. The integration of advanced features in modern thoracic drainage devices, such as anti-reflux valves and infection control mechanisms, is enhancing the overall safety profile of these products. Furthermore, the availability of training programs for healthcare professionals on the proper use of thoracic drainage devices is supporting better patient management and outcomes. This focus on safety and efficacy is driving the adoption of thoracic drainage devices across various healthcare settings.

Moreover, the growing trend towards minimally invasive procedures in surgery and emergency care is influencing the adoption of thoracic drainage devices. As healthcare providers increasingly prefer techniques that reduce patient trauma, shorten recovery times, and improve surgical outcomes, thoracic drainage devices that facilitate these goals are gaining popularity. These devices allow for the effective management of thoracic complications with minimal disruption to surrounding tissues. The trend towards minimally invasive interventions is particularly evident in procedures such as video-assisted thoracoscopic surgery (VATS), where effective drainage solutions are critical for post-operative recovery. This shift towards minimally invasive practices is contributing to the growth of the thoracic drainage devices market.

What Is Driving the Growth of the Global Thoracic Drainage Devices Market?

The growth in the global Thoracic Drainage Devices market is driven by several factors, including rising investments in healthcare infrastructure, increasing demand for advanced medical technologies, and the growing focus on patient-centered care. One of the primary growth drivers is the rising investment in healthcare infrastructure aimed at improving patient outcomes and expanding access to quality medical care. Governments and healthcare organizations are increasingly allocating resources to enhance medical facilities, particularly in emerging economies, which is leading to an increased adoption of advanced medical devices, including thoracic drainage systems. The demand for effective management of respiratory conditions and thoracic interventions is driving investments in healthcare infrastructure, thereby supporting the growth of the thoracic drainage devices market.

Another significant driver of market growth is the increasing demand for advanced medical technologies that enhance patient care and safety. Healthcare providers are recognizing the importance of utilizing modern thoracic drainage devices that incorporate advanced features, such as digital monitoring, improved biocompatibility, and user-friendly designs. These innovations are not only improving the efficiency of thoracic procedures but also enhancing patient experiences and outcomes. The focus on adopting advanced medical technologies to ensure better clinical management is driving the demand for thoracic drainage devices across healthcare settings.

Moreover, the growing focus on patient-centered care is supporting the growth of the thoracic drainage devices market. As healthcare moves towards more personalized and effective treatment approaches, the adoption of thoracic drainage devices that prioritize patient comfort, safety, and convenience is becoming increasingly important. Manufacturers are responding to this trend by developing devices that are easier to use, cause less discomfort, and promote faster recovery. The emphasis on patient-centered care is driving healthcare providers to seek out innovative solutions, thereby contributing to the growth of the thoracic drainage devices market.

Furthermore, advancements in training and educational programs for healthcare professionals are influencing the growth of the thoracic drainage devices market. As healthcare institutions invest in training initiatives to enhance the skills and knowledge of their staff, the adoption of thoracic drainage devices is expected to increase. Improved training leads to better patient management, reduced complications, and enhanced clinical outcomes, thereby encouraging healthcare providers to adopt these devices more widely. As these factors continue to shape the thoracic drainage devices landscape, the market is poised for robust growth, driven by rising investments in healthcare infrastructure, increasing demand for advanced medical technologies, and a growing focus on patient-centered care.

SCOPE OF STUDY:

The report analyzes the Thoracic Drainage Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Thoracic Surgery & Pulmonology, Cardiac Surgery, General Intensive Care & Emergency Medicine, Infectious Disease, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â